Skip to main content
. 2017 Feb 14;174(22):4043–4054. doi: 10.1111/bph.13707

Table 1.

Lipid levels and white blood cell counts for ApoE−/− × Fpr2+/+ and ApoE−/− × Fpr2−/− treated with either Vehicle or ATL

ApoE−/− × Fpr2+/+ ApoE−/− × Fpr2−/−
Vehicle (n = 11) ATL (n = 8) Vehicle (n = 7) ATL (n = 6)
Lipids
Cholesterol (mM) 9.2±0.5 9.4±0.6 9.8 ± 0.5 7.5 ± 0.7 NS
Triglycerides (mM) 1.4±0.1 0.9±0.1 1.2 ± 0.1 1.3 ± 0.1 NS
White blood cell count (109 L−1) 6.2 ± 0.5 5.9 ± 0.5 7.3 ± 0.7 8.6 ± 1.0 NS
Lymphocyte (%) 70.9 ± 1.0 70.8 ± 1.1 71.2 ± 1.8 72.6 ± 2.4 NS
Monocyte (%) 4.3 ± 0.2 3.5 ± 0.2 4.8 ± 0.2 4.7 ± 0.1 NS
Granulocyte (%) 24.5 ± 0.9 25.6 ± 1.0 23.9 ± 1.8 22.6 ± 2.4 NS
Body weight (g) 25.6 ± 0.4 26.7 ± 0.3 25.3 ± 0.5 26.3 ± 0.7 NS

Results are presented as mean ± SEM; NS, non‐significant (P > 0.05; one way ANOVA).